Regulatory role of interleukin-10 in experimental group B streptococcal arthritis

Infection and Immunity

Volumn 70, Issue 6, 2002, Pages 2862-2868

  Puliti, Manuela ^a   Von Hunolstein, Christina ^a   Verwaerde, Claudie ^a   Bistoni, Francesco ^a   Orefici, Graziella ^a   Tissi, Luciana ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTHRITIS; ARTICLE; BACTERIAL ARTHRITIS; CLINICAL OBSERVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOPATHOLOGY; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFLAMMATION; JOINT; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERUM; STREPTOCOCCUS AGALACTIAE;

ANIMALS; ARTHRITIS, INFECTIOUS; DISEASE MODELS, ANIMAL; FEMALE; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MICE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036262992     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.6.2862-2868.2002     Document Type: Article

References (55)

1. Regulation of macrophage inflammatory protein-1 alpha expression and function by endogenous interleukin-10 in a model of acute inflammation
2. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis
3. Group B streptococcal infections
4. Macrophage deactivation by interleukin-10
5. The neutrophil: One of the cellular targets of interleukin-10
6. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide
7. IL-10: A novel cytotoxic T cell differentiation factor
8. Group B streptococcal bacteremia in adults at Hartford Hospital 1991-1996
9. Interleukin-10 protects neonatal mice from lethal group B streptococcal infection
10. Immunosuppressive and antiinflammatory properties of interleukin 10
11. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregolatory role of IL-10 produced by monocytes
12. Cytokine mRNA profiles during the course of experimental Haemophilus influenzae bacterial meningitis
13. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant women
14. IL-10 inhibits cytokine production by activated macrophages
15. IL-10 acts on the antigen presenting cells to inhibit cytokine production by Th1 cells
16. Group B streptococcal necrotizing fasciitis and streptococcal toxic shock-like syndrome in adults
17. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia
18. Interleukin-10, a novel B cell stimulatory factor: Unresponsiveness of X-chromosome-linked immunodeficiency B cells
19. Interleukin-6 attenuates agonist-mediated calcium mobilization in murine osteoblastic cells
20. IL-9 protects mice from gram-negative bacterial shock: Suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10
21. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis
22. Exogenously administered interleukin-10 decreases pulmonary neutrophil infiltration in a tumor necrosis factor-dependent murine model of acute visceral ischemia
23. Interleukin-10 inhibits macrophage-induced glomeruly injury
24. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice
25. Effects of interleukin-6 on the metabolism of the connective tissue components in rheumatoid synovial fibroblasts
26. Risk factors for group B streptococcal disease in adults
27. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction
28. Interleukin-10 expression and chemokine regulation during the evolution of the murine type II collagen-induced arthritis
29. Immunoregulatory role of interleukin-10 in rheumatoid arthritis
30. Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone
31. IL-10, a novel growth cofactor for mature and immature T cells
32. Interleukin-10
33. Differential in vitro effects of IL-4, IL-10, and IL-13 on proinflammatory cytokine production and fibroblast proliferation in rheumatoid synovium
34. Properties and functions of interleukin-10
35. B7 and interleukin-12 cooperate for proliferation and interferon-gamma production by mouse T helper clones that are unresponsive to B7 costimulation
36. Interleukin-1-induced interleukin-6 is required for the inhibition of proteoglycan synthesis by interleukin-1 in human articular cartilage
37. Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameloriates sustained arthritis in rats
38. Severity of group B streptococcal arthritis is correlated with β-hemolysin expression
39. Interleukin 10 prevents experimental allergic encephalomyelitis
40. Recurrent group B streptococcal arthritis
41. Bacterial arthritis due to beta-hemolytic streptococci of serogroups A, B, C, F, and G. Analysis of 23 cases and a review for literature
42. Group B streptococcal arthritis in adults
43. Destructive polyarthritis due to a group B streptococcus
44. Effect of IL-10 on collagen-induced arthritis in mice
45. Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection
46. Production of tumor necrosis factor-α and interleukin-6 in mice infected with group B streptococci
47. Tumor necrosis factor alpha and beta induce osteoblastic cells to stimulate osteoclast bone resorption
48. Interleukin-10: A novel stimulatory factor for mast cells and their progenitors
49. Experimental group B Streptococcus arthritis in mice
50. Experimental model of type IV Streptococcus agalactiae (group B Streptococcus) infection in mice with early development of septic arthritis
51. Role of tumor necrosis factor alpha, interleukin-1β, and interleukin-6 in a mouse model of group B streptococcal arthritis
52. Role of group B streptococcal capsular polysaccharides in the induction of septic arthritis
53. Role of intreleukin-1, tumor necrosis factor α, and interleukin-6 in cartilage proteoglycan metabolism and destruction
54. Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus
55. Interleukin-10 inhibition of the progression of established collagen-induced arthritis